COMET Initiative | Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators

Guidelines for controlled trials of drugs in migraine: third edition. A guide for investigators

Not provided

Aim

The third edition of Migraine Clinical Trials Guidelines is a consensus summary that was developed by experts in the field, and its purpose is to recommend a contemporary, standardized, and evidence-based approach to the conduct and reporting of migraine RCTs.

Contributors

Tfelt-Hansen, P. Pascual, J. Ramadan, N. Dahlof, C. D'Amico, D. Diener, H. C. Hansen, J. M. Lanteri-Minet, M. Loder, E. McCrory, D. Plancade, S. Schwedt, T. International Headache Society Clinical Trials, Subcommittee

Publication

Journal: Cephalalgia
Volume: 32
Issue: 1
Pages: 6 - 38
Year: 2012
DOI: 10.1177/0333102411417901

Further Study Information

Current Stage: Not Applicable
Date:
Funding source(s): Not stated

Health Area

Disease Category: Neurology

Disease Name: Migraine

Target Population

Age Range: 18 - 65

Sex: Either

Nature of Intervention: Drug

Stakeholders Involved

- Clinical experts
- Other (unknown)

Study Type

- Recommendations for outcome measures (measurement/how)
- COS for clinical trials or clinical research